HIV treatment and prevention on every 2026 Connecticut Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Connecticut cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
11 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Humana Basic Rx Plan$8.40/moS5884-102 | Wellcare Value Script$16.40/moS4802-137 | Blue MedicareRx Value Plus$20.70/moS2893-001 | Wellcare Classic$21.70/moS4802-076 | SilverScript Choice$32.70/moS5601-004 | AARP Medicare Rx Saver from UHC$38.70/moS5921-348 | Humana Value Rx Plan$73.60/moS5884-182 | Humana Premier Rx Plan$138.60/moS5884-149 | HealthSpring Assurance Rx$139.30/moS5617-008 | AARP Medicare Rx Preferred from UHC$155.10/moS5921-385 | Blue MedicareRx Premier$238.60/moS2893-003 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biktarvybictegravir/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 533% |
| Dovatodolutegravir and lamivudine | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 533% |
| Triumeqabacavir/dolutegravir/lamivudine | Tier 432%QL 180/30d | Tier 440% | Tier 432% | Tier 429% | Tier 435% | Tier 435%QL 180/30d | Tier 431%QL 180/30d | Tier 450%QL 180/30d | Tier 431%QL 300/30d | Tier 430%QL 180/30d | Tier 435% |
| Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 533% |
| Odefseyemtricitabine/rilpivirine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 533% |
| Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 533% |
| Julucadolutegravir and rilpivirine | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 533% |
| Descovyemtricitabine and tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 533%QL 30/30d | Tier 525%QL 30/30d | Tier 531%QL 30/30d | Tier 533% |
| Truvadaemtricitabine and tenofovir disoproxil | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| emtricitabine-tenofovirgeneric Truvada | Tier 432%QL 30/30d | Tier 440%QL 30/30d | Tier 432% | Tier 429%QL 30/30d | Tier 435%QL 30/30d | Tier 435%QL 30/30d | Tier 431%QL 30/30d | Tier 450%QL 30/30d | Tier 431%QL 30/30d | Tier 430%QL 30/30d | Tier 435% |
| Tivicaydolutegravir | Tier 525%QL 60/30d | Tier 525% | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 60/30d | Tier 526%QL 60/30d | Tier 533%QL 60/30d | Tier 431%QL 180/30d | Tier 531%QL 60/30d | Tier 533% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.